Kefir peptides show promise for kidney health
NCT ID NCT07260292
First seen Jun 27, 2026 · Last updated Sep 02, 2026 · Updated 2 times
Summary
This study looked at whether taking kefir peptides for three months could help people with stage 3 or 4 chronic kidney disease. Researchers measured kidney function, protein in urine, and signs of inflammation. The goal was to see if this supplement could support disease control, not cure the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
165 people
The number who actually took part.
- Started
-
Feb 2023
- Finished
-
Aug 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 82 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age: 30-82 years of age * Chronic kidney disease stage 3 and 4 * Sign informed consent Exclusion Criteria: * Acute illness * Pregnancy * Aboriginal descent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic kidney disease stage 3 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jen-Ai Hospital
Taichung, 412, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a ketone drink shield kidneys?
- A conversation starter for kidney care: can a checklist give older patients a stronger voice?
- Can light therapy speed up dialysis fistula healing?
- Blood test could predict who faces rapid kidney decline in diabetes
- AI therapy coach aims to ease distress in seriously ill seniors
- Zapping kidney nerves: a new hope for stubborn high blood pressure?